{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:43:24Z","timestamp":1787510604190,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Shandong Provincial Natural Science Foundation of China","award":["no. ZR2019MH120"],"award-info":[{"award-number":["no. ZR2019MH120"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Steroid-induced osteonecrosis of the femoral head (SONFH) is the predominant cause of non-traumatic osteonecrosis of the femoral head (ONFH). Impaired blood supply and reduced osteogenic activity of the femoral head are the key pathogenic mechanisms of SONFH. Fibroblast growth factor 23 (FGF23) levels are not only a biomarker for early vascular lesions caused by abnormal mineral metabolism, but can also act directly on the peripheral vascular system, leading to vascular pathology. The aim of this study was to observe the role of FGF23 on bone microarchitecture and vascular endothelium, and to investigate activation of pyroptosis in SONFH. Lipopolysaccharide (LPS) combined with methylprednisolone (MPS) was applied for SONFH mouse models, and adenovirus was used to increase or decrease the level of FGF23. Micro-CT and histopathological staining were used to observe the structure of the femoral head, and immunohistochemical staining was used to observe the vascular density. The cells were further cultured in vitro and placed in a hypoxic environment for 12\u00a0h to simulate the microenvironment of vascular injury during SONFH. The effect of FGF23 on osteogenic differentiation was evaluated using alkaline phosphatase staining, alizarin red S staining and expression of bone formation-related proteins. Matrigel tube formation assay in vitro and immunofluorescence were used to detect the ability of FGF23 to affect endothelial cell angiogenesis. Steroids activated the pyroptosis signaling pathway, promoted the secretion of inflammatory factors in SONFH models, led to vascular endothelial dysfunction and damaged the femoral head structure. In addition, FGF23 inhibited the HUVECs angiogenesis and BMSCs osteogenic differentiation. FGF23 silencing attenuated steroid-induced osteonecrosis of the femoral head by inhibiting the pyroptosis signaling pathway, and promoting osteogenic differentiation of BMSCs and angiogenesis of HUVECs in vitro.<\/jats:p>","DOI":"10.1038\/s41598-024-66799-z","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T09:02:16Z","timestamp":1721034136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Fibroblast growth factor 23 inhibition attenuates steroid-induced osteonecrosis of the femoral head through pyroptosis"],"prefix":"10.1038","volume":"14","author":[{"given":"Lun","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beilei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"66799_CR1","first-page":"100","volume":"21","author":"D Zhao","year":"2020","unstructured":"Zhao, D. et al. Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version). J. Orthop. Transl. 21, 100\u2013110 (2020).","journal-title":"J. Orthop. Transl."},{"issue":"3\u20135","key":"66799_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jsbmb.2009.02.007","volume":"114","author":"MA Kerachian","year":"2009","unstructured":"Kerachian, M. A., Seguin, C. & Harvey, E. J. Glucocorticoids in osteonecrosis of the femoral head: A new understanding of the mechanisms of action. J. Steroid Biochem. Mol. Biol. 114(3\u20135), 121\u2013128 (2009).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"66799_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.gene.2018.05.091","volume":"671","author":"A Wang","year":"2018","unstructured":"Wang, A., Ren, M. & Wang, J. The pathogenesis of steroid-induced osteonecrosis of the femoral head: A systematic review of the literature. Gene 671, 103\u2013109 (2018).","journal-title":"Gene"},{"key":"66799_CR4","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1002\/ptr.7028","volume":"35","author":"D Zhu","year":"2021","unstructured":"Zhu, D. et al. Calycosin modulates inflammation via suppressing TLR4\/NF-\u03baB pathway and promotes bone formation to ameliorate glucocorticoid-induced osteonecrosis of the femoral head in rat. Phytother. Res. 35, 2824\u20132835 (2021).","journal-title":"Phytother. Res."},{"issue":"1","key":"66799_CR5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13287-020-01658-y","volume":"11","author":"X Yao","year":"2020","unstructured":"Yao, X. et al. PTEN inhibitor VO-OHpic attenuates GC-associated endothelial progenitor cell dysfunction and osteonecrosis of the femoral head via activating Nrf2 signaling and inhibiting mitochondrial apoptosis pathway. Stem Cell Res. Ther. 11(1), 140 (2020).","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"66799_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","volume":"14","author":"SS Beck-Nielsen","year":"2019","unstructured":"Beck-Nielsen, S. S. et al. FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J. Rare Dis. 14(1), 58 (2019).","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"66799_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"ADHR Consortium","year":"2000","unstructured":"ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 26(3), 345\u2013348 (2000).","journal-title":"Nat. Genet."},{"key":"66799_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.mce.2014.10.007","volume":"399","author":"N Ito","year":"2015","unstructured":"Ito, N. et al. Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli. Mol. Cell. Endocrinol. 399, 208\u2013218 (2015).","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"66799_CR9","doi-asserted-by":"publisher","first-page":"E426","DOI":"10.1152\/ajpendo.00264.2014","volume":"307","author":"N Silswal","year":"2014","unstructured":"Silswal, N. et al. FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability. Am. J. Physiol. Endocrinol. Metab. 307(5), E426\u2013E436 (2014).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"66799_CR10","doi-asserted-by":"publisher","first-page":"e0176817","DOI":"10.1371\/journal.pone.0176817","volume":"12","author":"MA Deli","year":"2017","unstructured":"Deli, M. A. et al. \u03b1-Klotho expression determines nitric oxide synthesis in response to FGF-23 in human aortic endothelial cells. PLoS One 12(5), e0176817 (2017).","journal-title":"PLoS One"},{"issue":"7","key":"66799_CR11","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00264-018-3994-8","volume":"42","author":"P Luo","year":"2018","unstructured":"Luo, P., Gao, F., Han, J., Sun, W. & Li, Z. The role of autophagy in steroid necrosis of the femoral head: A comprehensive research review. Int. Orthop. 42(7), 1747\u20131753 (2018).","journal-title":"Int. Orthop."},{"issue":"1","key":"66799_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/imr.12287","volume":"265","author":"I Jorgensen","year":"2015","unstructured":"Jorgensen, I. & Miao, E. A. Pyroptotic cell death defends against intracellular pathogens. Immunol. Rev. 265(1), 130\u2013142 (2015).","journal-title":"Immunol. Rev."},{"issue":"5","key":"66799_CR13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/sctm.20-0346","volume":"10","author":"H Xu","year":"2021","unstructured":"Xu, H. et al. Cotransplantation of mesenchymal stem cells and endothelial progenitor cells for treating steroid-induced osteonecrosis of the femoral head. Stem Cells Transl. Med. 10(5), 781\u2013796 (2021).","journal-title":"Stem Cells Transl. Med."},{"issue":"3","key":"66799_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/jbmr.4207","volume":"36","author":"Z Zhang","year":"2021","unstructured":"Zhang, Z. et al. Osteoblasts\/osteocytes sirtuin6 is vital to preventing ischemic osteonecrosis through targeting VDR-RANKL signaling. J. Bone Miner. Res. 36(3), 579\u2013590 (2021).","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"66799_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/cdd.2017.144","volume":"25","author":"J Gao","year":"2018","unstructured":"Gao, J. et al. SIRT3\/SOD2 maintains osteoblast differentiation and bone formation by regulating mitochondrial stress. Cell Death Differ. 25(2), 229\u2013240 (2018).","journal-title":"Cell Death Differ."},{"key":"66799_CR16","doi-asserted-by":"publisher","first-page":"6360133","DOI":"10.1155\/2022\/6360133","volume":"2022","author":"L Fang","year":"2022","unstructured":"Fang, L. et al. SIRT6 prevents glucocorticoid-induced osteonecrosis of the femoral head in rats. Oxid. Med. Cell Longev. 2022, 6360133 (2022).","journal-title":"Oxid. Med. Cell Longev."},{"issue":"1","key":"66799_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41420-022-00906-9","volume":"8","author":"F Yao","year":"2022","unstructured":"Yao, F. et al. HDAC11 promotes both NLRP3\/caspase-1\/GSDMD and caspase-3\/GSDME pathways causing pyroptosis via ERG in vascular endothelial cells. Cell Death Discov. 8(1), 112 (2022).","journal-title":"Cell Death Discov."},{"issue":"2","key":"66799_CR18","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.5659","volume":"254","author":"M Ruh","year":"2021","unstructured":"Ruh, M. et al. The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma. J. Pathol. 254(2), 199\u2013211 (2021).","journal-title":"J. Pathol."},{"issue":"10","key":"66799_CR19","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/jbmr.3761","volume":"34","author":"\u00c1 Delucchi","year":"2019","unstructured":"Delucchi, \u00c1. et al. Glucocorticoids decrease longitudinal bone growth in pediatric kidney transplant recipients by stimulating the FGF23\/FGFR3 signaling pathway. J. Bone Miner. Res. 34(10), 1851\u20131861 (2019).","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"66799_CR20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.kint.2017.02.014","volume":"92","author":"H Komaba","year":"2017","unstructured":"Komaba, H. et al. Klotho expression in osteocytes regulates bone metabolism and controls bone formation. Kidney Int. 92(3), 599\u2013611 (2017).","journal-title":"Kidney Int."},{"issue":"6","key":"66799_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1359\/jbmr.080220","volume":"23","author":"H Wang","year":"2008","unstructured":"Wang, H. et al. Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J. Bone Miner. Res. 23(6), 939\u2013948 (2008).","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"66799_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12882-020-02203-y","volume":"22","author":"K Kajiwara","year":"2021","unstructured":"Kajiwara, K., Sawa, Y., Fujita, T. & Tamaoki, S. Immunohistochemical study for the expression of leukocyte adhesion molecules, and FGF23 and ACE2 in P. gingivalis LPS-induced diabetic nephropathy. BMC Nephrol. 22(1), 3 (2021).","journal-title":"BMC Nephrol."},{"issue":"2","key":"66799_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5551\/jat.63460","volume":"30","author":"LW Guo","year":"2023","unstructured":"Guo, L. W., Wang, Y. K., Li, S. J., Yin, G. T. & Li, D. Elevated fibroblast growth factor 23 impairs endothelial function through the NF-\u03baB signaling pathway. J. Atheroscler. Thromb. 30(2), 138\u2013149 (2023).","journal-title":"J. Atheroscler. Thromb."},{"issue":"1","key":"66799_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13046-021-01959-x","volume":"40","author":"Y Tan","year":"2021","unstructured":"Tan, Y. et al. Pyroptosis: A new paradigm of cell death for fighting against cancer. J. Exp. Clin. Cancer Res. 40(1), 153 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"66799_CR25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.bbrc.2017.02.007","volume":"484","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. NLRP3 inflammasome activation in mesenchymal stem cells inhibits osteogenic differentiation and enhances adipogenic differentiation. Biochem. Biophys. Res. Commun. 484(4), 871\u2013877 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"66799_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ebiom.2018.05.023","volume":"32","author":"Y Chen","year":"2018","unstructured":"Chen, Y. et al. Mesenchymal stromal cells directly promote inflammation by canonical NLRP3 and non-canonical caspase-11 inflammasomes. EBioMedicine 32, 31\u201342 (2018).","journal-title":"EBioMedicine"},{"issue":"12","key":"66799_CR27","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41419-019-2157-1","volume":"10","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-\u03baB signaling. Cell Death Dis. 10(12), 906 (2019).","journal-title":"Cell Death Dis."},{"issue":"1","key":"66799_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2741\/4383","volume":"21","author":"YF Li","year":"2016","unstructured":"Li, Y. F. et al. Caspase-1 mediates hyperlipidemia-weakened progenitor cell vessel repair. Front. Biosci. (Landmark Ed.) 21(1), 178\u2013191 (2016).","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"4","key":"66799_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ame2.12194","volume":"4","author":"LJ Yan","year":"2021","unstructured":"Yan, L. J. Folic acid-induced animal model of kidney disease. Anim. Model Exp. Med. 4(4), 329\u2013342 (2021).","journal-title":"Anim. Model Exp. Med."},{"issue":"1","key":"66799_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41413-023-00259-8","volume":"11","author":"F Zhang","year":"2023","unstructured":"Zhang, F. et al. FAR591 promotes the pathogenesis and progression of SONFH by regulating Fos expression to mediate the apoptosis of bone microvascular endothelial cells. Bone Res. 11(1), 27 (2023).","journal-title":"Bone Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66799-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66799-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66799-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T09:09:45Z","timestamp":1721034585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-66799-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["66799"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-66799-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3897523\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,15]]},"assertion":[{"value":"25 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16270"}}